Birdwatch Note
2023-07-04 13:53:42 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A vacina contra dengue da Takeda, chamada Qdenga, foi aprovada pela Anvisa em março de 2023 para uso em indivíduos de 4 a 60 anos de idade. No entanto, não posso confirmar se ela será comercializada atualmente por clínicas privadas. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-aprova-nova-vacina-para-a-dengue https://www.takeda.com/pt-br/Newsroom/releases/2023/vacina-qdenga-vacina-dengue-1-2-3-e-4-atenuada-da-takeda-e-aprovada-no-brasil-para-uso-independentemente-de-exposicao-previa-a-dengue/ https://agenciabrasil.ebc.com.br/en/saude/noticia/2023-03/new-vaccine-against-dengue-fever-approved-brazil
Written by 969BB058905AB5834D721A0BD025E4353E1631B9F6260BBCDAA13338BEE54594
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1676034788661010435
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1676227789601615872
- noteId - 1676227789601615872
- participantId -
- noteAuthorParticipantId - 969BB058905AB5834D721A0BD025E4353E1631B9F6260BBCDAA13338BEE54594 Participant Details
- createdAtMillis - 1688478822503
- tweetId - 1676034788661010435
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A vacina contra dengue da Takeda, chamada Qdenga, foi aprovada pela Anvisa em março de 2023 para uso em indivíduos de 4 a 60 anos de idade. No entanto, não posso confirmar se ela será comercializada atualmente por clínicas privadas. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-aprova-nova-vacina-para-a-dengue https://www.takeda.com/pt-br/Newsroom/releases/2023/vacina-qdenga-vacina-dengue-1-2-3-e-4-atenuada-da-takeda-e-aprovada-no-brasil-para-uso-independentemente-de-exposicao-previa-a-dengue/ https://agenciabrasil.ebc.com.br/en/saude/noticia/2023-03/new-vaccine-against-dengue-fever-approved-brazil
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-07-04 13:53:42 UTC (1688478822503) |
1969-12-31 23:59:59 UTC (-1) |
2023-07-05 02:12:43 UTC (1688523163429) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-07-04 12:52:38 -0500 | Rating Details | |
| 2023-07-04 11:48:37 -0500 | Rating Details | |
| 2023-07-04 10:55:17 -0500 | Rating Details | |
| 2023-07-05 17:15:53 -0500 | Rating Details |